Stock & Company Details
Cellectar Biosciences Inc $CLRB
Price:
N/A
N/A
9.5M
$13M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.19
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CLRB technical indicators
Latest Cellectar Biosciences Inc (CLRB) indicator readings as of 2026-10-09.
CLRB's 14-day RSI is 18.6, in oversold territory. At $1.45 it is trading 47.8% below its 200-day moving average of $2.78, and below its 50-day average of $2.29. Price sits near the lower Bollinger Band ($1.28 to $2.61). ADX reads 34.6, indicating a trending market.
Overview
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Finance Bot
Ask your questions
Start by typing a question below.
